Analystreport

Evelo Biosciences Inc (NASDAQ: EVLO) had its "neutral" rating re-affirmed by analysts at Chardan Capital.

Evelo Biosciences, Inc.  (EVLO) 
Last evelo biosciences, inc. earnings: 2/13 07:00 am Check Earnings Report